MedPath

Randomized trial comparing efficacy of 12.5 and 25 µg oral misoprostol 2 hourly for induction of labor

Phase 3
Conditions
Induction of labor in maternal and fetal condition
Induction of labor &#44
misoprostol &#44
success rate
Registration Number
TCTR20191230002
Lead Sponsor
donthani hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
Female
Target Recruitment
160
Inclusion Criteria

women with singleton live pregnancy , Gestational age greater than or equal to 38 weeks , have indication of induction of labor , vertex presentation, normal fetal heart rate , Bishop score less than or equal to 6 point , intact membrane

Exclusion Criteria

refuse participate in research , misoprostol allergy , previous cesarean section or myomectomy ,underlying disease such as heart, renal ,liver disease ,severe preeclampsia with severe feature , Grand multiparity ,regular uterine contraction , multifetal pregnancy , active genital tract disease , DFIU and fetal anomaly , estimate fetal weight more than 4000 grams

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of successful induction of labor within 24 hours , comparing 12.5 and 25 µg oral misoprostol Induction time to delivery time successful induction of labor was defined as vaginal delivery within 24 hr can be achieved
Secondary Outcome Measures
NameTimeMethod
maternal and neonatal outcome after delivery period analyzed data of maternal and neonatal outcome after delivery,rate of uterine tachysystole , rate of cesarean section after delivery period record data and analyzed data after delivery
© Copyright 2025. All Rights Reserved by MedPath